Godrej Agrovet Q1 FY27 Earnings Call: Trims PBT Guidance To Double-Digit Growth, Cattle Feed Volumes Surge 15% (GODREJAGRO)

Godrej Agrovet Ltd held its Q1 FY27 earnings call on August 05, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Consolidated Revenue of Rs.2,852 Cr with 10% YoY Growth

• Rs.2,852 crore consolidated revenue for Q1 FY 2026-2027, representing year-on-year growth of 10%
• Animal nutrition segment revenue grew 12.6% YoY, with cattle feed volume surging 15% and segment results growing 29%
• Oil palm segment revenue grew 28.9% YoY and segment result grew 14.4%, driven by higher CPO and PKO realizations
• Dairy business revenue grew 11.4% YoY, with value-added product salience increasing from 42% to 49% of sales
• Astec LifeSciences sustained EBITDA break-even in Q1 FY 2026-2027, compared to an EBITDA loss of Rs.11 crore in Q1 FY 2025-2026
• Standalone crop care business revenue declined 3.2% YoY, impacted by a delayed monsoon and slower Kharif sowing
• Bangladesh JV (ACI Godrej Agrovet) returned to double-digit growth in volume, revenue, and PBT in Q1 FY 2026-2027

Cattle Feed Volumes Surge 15% as Poultry Rationalization Continues

• 60-70% of maize price increases were passed on to the market in Q1 FY 2026-2027, with management maintaining pricing discipline
• EBIT per tonne of Rs.2,100-2,150 for Q1 FY 2026-2027, slightly above the guided Rs.2,100-2,250 range (guidance maintained for full FY 2026-2027)
• Poultry volumes were selectively reduced in unprofitable segments as part of a geography-focused rationalization strategy
• Fish feed volumes grew 20%+ in Q1 FY 2026-2027, now representing ~7% of the total animal nutrition segment (cattle feed is 55-56%)
• Bangladesh business turnaround began with double-digit volume growth in Q1 FY 2026-2027
• Live bird trading to be phased down by 15-20% per quarter over 3-4 years, with management "targeting marginalization to Rs.20-30 crore within 5 years" (by ~FY 2031-2032)

Revenue Grows 28.9% with Long-Term Expansion on Track

• FFB volumes in Q1 FY 2026-2027 were flat YoY due to a drier June versus a very strong Q1 FY 2025-2026
• Oil extraction rate (OER) improved from 18.4% in Q1 FY 2025-2026 to 18.8% in Q1 FY 2026-2027
• Management guided to high single-digit to double-digit FFB volume growth for the full FY 2026-2027
• Long-term target: FFB volume growth at "high single-digit to early double-digit over the next 4-5 years (LRP period)", driven by area expansion adding ~17,000 hectares in FY 2025-2026 and on track for similar in FY 2026-2027
• Geographic diversification into Telangana and Northeast, with LRP plan to "move from ~80,000 to ~150,000 hectares"
• ~50% of plantations in juvenile stage (0-4 years) coming into production, providing a demographic dividend
• India's first integrated palm oil complex rolled out in Khammam; first specialty fats refinery expected end-August/early September FY 2026-2027
• When fully scaled, downstream is expected to add ~200 bps to overall EBITDA margin; capex filter requires IRR of 16-18% for new assets

Soft Q1 Due to Monsoon Deficit; New Products and H2 Recovery Expected

• Crop care had a soft Q1 FY 2026-2027 due to India's worst June in a century (40% rainfall deficit); July is tracking better than July FY 2025-2026
• Management attributed the decline to macro environment impacting cotton herbicide, not execution issues, noting concentration in that segment
• New products Ashitaka and Sakai together contributed 18-20% of Q1 FY 2026-2027 sales in their first season; margins will be lower than Hit Rate margins due to in-licensing vs. in-house products, but expected to improve with scale
• Positive H2 FY 2026-2027 drivers: softer base, new products (maize herbicide Asitaka, insecticide Takai, soybean herbicide Ghashnash), and expected normal weather for chili/grape products (Gracia, Combine)
• Crop care EBITDA margin target for FY 2026-2027 is ~26-27%, despite a tough year, driven by cost projects and scale benefits
• Astec LifeSciences: FY 2026-2027 revenue guidance revised upward to "more than 20% growth" (from earlier ~20%); Q1 dip of ~8-9% expected to be recovered; CDMO salience guided at ~50-52%; enterprise margins normalizing after Q1 raw-material advantage

Dairy Margins Under Pressure as B2C Food Business Gains Traction

• CDPL (dairy) volumes grew 8% in Q1 FY 2026-2027, translating to 11.5% value growth — a recovery after several quarters but margins under pressure
• Dairy margins impacted by two one-off factors: (1) packaging inflation from Middle East conflict (expected to normalise by August 2026) and (2) elevated milk procurement prices (expected to persist for 2-3 quarters); ~70% of milk cost inflation was passed on
• Dairy strategic shift: 18-20 month route-to-market transformation (pilot starting in coming months), premiumisation of value-added portfolio, and cost initiatives (Project PI) to mitigate margin pressure over H2 FY 2026-2027
• Godrej Foods B2C branded business (Yummiez, Real Good) grew 28% volume in Q1 FY 2026-2027 (vs 23-24% in FY 2025-2026), reaching 32% salience of total Godrej Foods
• New product launches in Q1 FY 2026-2027: frozen chicken momos (chicken/cheese, veg to follow), frozen chicken, and expanded nuggets line (Crispy Bites)
• Management targets to "transform Godrej Foods into a 65-70% B2C company by end of the LRP period", with healthy margins after an initial investment phase of 3-4 years

PBT Guidance Trimmed to Double-Digit Growth; Capex Maintained at Rs.300-350 Cr

• Consolidated PBT guidance: previously guided "mid-teens" growth for FY 2026-2027; management now confident of at least "double-digit" growth, with more clarity after Q2 FY 2026-2027 results
• FY 2026-2027 capex guidance of Rs.300-350 crore already covers palm oil diversification investments; no incremental spend required
• All labor code wage hike impacts have been fully factored into the P&L for FY 2026-2027, with no additional provisioning expected (CFO S. Varadaraj confirmed)
• No direct linkage exists between cattle feed and crop protection businesses; potential synergy between CDPL (dairy) and animal nutrition farmer networks is a future opportunity
• Management will provide full recovery outlook for crop care by end of Q2 FY 2026-2027 (September 2026)
• Oil palm margin recovery expected as FFB volume grows over the remainder of FY 2026-2027, providing scale efficiencies; Q1 margin decline attributed to one-off government pricing formula impact, not structural